3x5 Partners — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Good Therapeuticsgoodtherapeutics.com 𝕏Dec 2021acquired by Roche

Portfolio company acquired by Roche.

BiotechSeattle, US

John Mulligan(Executive Officer, Director, Promoter)inMitchell Mutz(Director)Nicholas Walrod(Director)

Board John McKearn(Director)inKarl Handelsman(Director)

Co-investorsDigitalis Ventures RiverVest Venture Partners Codon Capital Roche Venture Fund

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.